Inadequate bowel prep due to side effects of Ozempic and Mounjaro carries significant risk of missed lesions, canceled procedures and other complications.
Before any individual Ozempic lawsuits are prepared for trial, the court will address whether plaintiffs need specific testing results to establish they were diagnosed with gastroparesis.
Warning labels provided for users of the GLP-1 diabetes drug downplayed the risk of gastrointestinal side effects from Trulicity, lawsuit states.
Awareness of Ozempic and Wegovy side effects may be driving more younger patients to report adverse events linked to the drugs, researchers speculate.
Eli Lilly failed to warn users that side effects of Trulicity may cause gastroparesis, despite numerous studies, case reports and medical literature indicating that users may experience severe stomach paralysis.
Despite reported problems dating back to 2010, Novo Nordisk failed to warn doctors and users of Ozempic and Trulicity about the risk of gastroparesis, lawsuit warns.
Health experts warn Ozempic and Wegovy use before surgery may increase the risk of vomiting, nausea and suffocation while under anesthesia.
Drug companies spend billions of dollars on television commercials for drugs that are more expensive and less effective than other treatments, according to the findings
